Trials / Completed
CompletedNCT00959881
Study Evaluating The Coadministration of Begacestat And Donepezil
Combined Administration Of Begacestat And Donepezil: A Multiple-Dose Study In Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study examines the cardiac effects (effects on the heart) of administering donepezil and begacestat together to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Donepezil plus placebo | 5- and 10-mg tablets, single dose |
| DRUG | Donepezil | 5- and 10-mg tablets, single dose |
| DRUG | Begacestat | 6 x 50-mg capsules, single dose |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2009-08-17
- Last updated
- 2011-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00959881. Inclusion in this directory is not an endorsement.